Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines
- PMID: 2454731
Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines
Abstract
Formal proof for an involvement of autocrine stimulation in the disturbed growth of malignant cells has been difficult to obtain, in part due to lack of precise methods of assessing growth factor production and receptor occurrence. In this study we have analyzed the mRNA levels for two growth factors and the corresponding receptors in a number of established human malignant glioma cell lines. Twenty-one tested lines all contained transcripts for the platelet-derived growth factor (PDGF) A chain while 16-17 of 21 expressed the c-sis/PDGF B chain gene; these two genes were expressed independently of each other. PDGF receptor transcripts were present in 15-16 of the 21 lines. Transcripts for the epidermal growth factor receptor were found in all 15 tested lines, in 2 of them at high levels, and the corresponding ligand transforming growth factor-alpha was found in 11 of 15 lines. No amplification or structural rearrangements of the genes, as analyzed by Southern blot hybridization, could explain the varying expression of PDGF A and B chain transcripts or the elevated levels of epidermal growth factor receptor mRNA. A correlation was found between cell morphology and expression of growth factor and receptor mRNA in these lines. The highest amount of PDGF receptor transcripts was found in cells with fibroblast-like morphology, and c-sis/B chain transcripts were found in small cell types and in cells with astrocyte-like morphology, while no clear relationship was found between PDGF receptor and A chain transcript levels or between morphology and A chain transcripts. It is possible that the findings reflect a coordinated expression of these genes in the progenitor cells. In conclusion, the data imply the existence of two possible autocrine loops in human malignant glioma lines, affecting the PDGF and epidermal growth factor receptor pathways.
Similar articles
-
Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry.Cancer Res. 1992 Jun 15;52(12):3453-9. Cancer Res. 1992. PMID: 1317752
-
Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma.Cancer Res. 1986 Jan;46(1):332-40. Cancer Res. 1986. PMID: 2998609
-
Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor.Cancer Res. 1987 Sep 15;47(18):4953-60. Cancer Res. 1987. PMID: 3497714
-
Growth factors and oncogenes in human malignant glioma.Neurol Clin. 1985 Nov;3(4):785-99. Neurol Clin. 1985. PMID: 3001490 Review.
-
Platelet-derived growth factor in human glioma.Glia. 1995 Nov;15(3):257-63. doi: 10.1002/glia.440150307. Glia. 1995. PMID: 8586462 Review.
Cited by
-
The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.Neoplasia. 2005 Apr;7(4):397-406. doi: 10.1593/neo.04691. Neoplasia. 2005. PMID: 15967117 Free PMC article.
-
An antisense EGFR oligodeoxynucleotide enveloped in Lipofectin induces growth inhibition in human malignant gliomas in vitro.J Neurooncol. 1998 Sep;39(3):237-44. doi: 10.1023/a:1005903002865. J Neurooncol. 1998. PMID: 9821109
-
Signal transduction pathways and their relevance in human astrocytomas.J Neurooncol. 1997 Dec;35(3):223-48. doi: 10.1023/a:1005800114912. J Neurooncol. 1997. PMID: 9440022 Review.
-
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2558-62. doi: 10.1073/pnas.92.7.2558. Proc Natl Acad Sci U S A. 1995. Retraction in: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12069. doi: 10.1073/pnas.95.20.12069-a PMID: 7708684 Free PMC article. Retracted.
-
PDGF and PDGF receptors in glioma.Ups J Med Sci. 2012 May;117(2):99-112. doi: 10.3109/03009734.2012.665097. Epub 2012 Apr 17. Ups J Med Sci. 2012. PMID: 22509804 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials